HIV is covered in the AUGE plan. Sexually transmitted diseases have become a concern for health authorities not only because of the increase in HIV cases, but also because of Hepatitis A outbreaks these days in MR, Valparaíso, Antofagasta and Temuco, or increased cases of other diseases, such as gonorrhea. The new anti-HIV campaign that the government will launch in August – includes other sexually transmitted diseases. It will emphasize the use of condoms as the main method of prevention of contagion and the importance of conducting diagnostic tests. The campaign targets different at-risk groups, such as men who have sex with men, indigenous peoples and immigrants. In parallel, the HIV treatment protocol was updated to standardize the treatments – to reduce the prescribed medications from more than 400 combinations to no more than 13. The drugs that are now included in the protocol are the safest and generate less resistance. These changes will be enforceable once the correction to the latest AUGE decree, envisaged for 2018, comes into force and will guarantee therapy for all HIV patients. According to Isapres, the change will make spending on HIV treatment grow by 25% a year.

Economiaynegocios

The North America region has the highest share in the market, with the United States being the major contributor. However, markets such as the Asia- Pacific are promising to exhibit the fastest growth in the forecast period. Factors such as a large patient base and increasing investments in healthcare sectors in countries like China and Japan are proving favorable for the market growth. Despite the increasing competition, the neurostimulation devices market will continue to be dominated by North America owing to factors such as continual support and interest of global investors thanks to the advances in technology and the government’s increased focus on improving patient safety and procedure efficiency by using neurostimulation devices.

The major players in the market include St Jude Medical, Medtronic, Boston Scientific, Aleva Neurotherapeutics, Cogentix Medical, Depuy Synthes Companies, Dr. Langer Medical GMBH, EBS Technologies, Intrapace, Neurological Surgery PC, Neuronetics, Nevro, and the Magstim Company.

The Peruvian medical device and equipment market exhibited 13% growth from 2014 to 2016, going from 333 million units to 428 million units. The market value, meanwhile, remained stable at just over $435 million, indicative of the Peruvian sol’s depreciation and cost pressures being faced by manufacturers and distributors across the region.

Download the complete report for more information.

Go Further

While our report offers a strong handle on these growth within Peru, it won’t let you know equipment counts for specific hospitals in Peru so you can see which ones offer the best sales opportunities. For that, you need the deep granular detail available in our hospital database, which lets you see equipment counts for Peru’s hospitals, key contacts for purchase and much more. Contact us to subscribe to our database so you can get started today on uncovering new sales from the Peruvian hospital market.

Beyond that, we can also help with fresh data on LatAm medical equipment market share so you can see where you stand in comparison to your competitors or deliver some custom LatAm healthcare market research to further help you edge out the competition with crucial market intelligence.

The self- tests were first launched Rio de Janeiro, followed by Sao Paulo and Espírito Santo. By the end of the month they are expected to reach the whole territory. The “self-test”, approved by the National Agency of Sanitary Surveillance (Anvisa), allows the user to know if he is carrying the AIDS virus, which is very useful in a country of more than 200 million inhabitants where the people are often reluctant to go to diagnostic centers.

According to data from the Fiocruz public medical research foundation, approximately 20% of the 800,000 HIV-positive people in Mexico are unaware that they are HIV-positive. The sooner the virus is detected, the better it is treated. The problem is that many Brazilians do not get tested in the hospital, out of shame or fear of being victims of discrimination.

The “self-tests” are already commercialized in countries like United States, United Kingdom and France. Brazil offers free treatment to anyone diagnosed as HIV positive. The test was developed by a local company OrangeLife. The test works by collecting a drop of blood mixed with a reactive product to detect antibodies that signal exposure to HIV. With a price between 60-70 reais (USD18-21 dollars), the result is known in 20 minutes.

The manufacturers claim the test is 99.9% accurate and reliable, a rate that surpasses the detection capability of tests that use saliva and are marketed in the United States. According to the company OrangeLife, the tests are produced in a factory in Rio with a capacity to prepare 100,000 units per month. For all the stakeholders including pharmaceuticals, doctors, and the manufacturer, this test represents an important advance in the fight against HIV.

Telemedicine is vital to expand the borders and provides the tools necessary for a patient to choose the doctor of their choice. Argentina generates approximately USD6 billion with export of Knowledge Based Services (SBC) that go through a cable and telemedicine is one among them.

The Omint health group of Argentina has an online medical platform for medical consultation through videoconference between a doctor and patient. Omint works with Instituto Cardiovascular de Buenos Aires (ICBA) on a program called “Balloon Gate” for patients with infraction. Once a patient calls for ambulance and in the times the ambulance reaches the Institute, patient data is sent to the clinic in electronic form reducing the diagnosis time and treating patient in the golden hour.

Argentina’s medical tourism is among the top five in Latin America and the low treatment prices drive the growth of this sector. As compared to the United States, surgeries in Argentina can cost up to four times less. Telemedicine is regarded as a fundamental technology for internationalization.

The new tool was presented during the Open Data on Health event in Brazil, by Google, in São Paulo.

The application offers online information on health and access to the data of the national health card, list of drugs withdrawn, vaccination card follow-up, list of examinations carried out, and other information.

The new tool once launched can be accessed on Apple and Android smartphones and tablets. The tool intends to use technology to integrate health data, improve the planning of activities and increase the access and quality of care provided to the population ultimately making the service more efficient.

This tool will aid in reducing wastage of services and connect patients to various stakeholders in the healthcare community.

Patients can access information from their location and avail the services nearest to their location. Citizens can lodge complaints of care and others online.

The tool has information from Hórus, Hemovida, Cartão SUS, CNES, e-sus AB, Ouvidoria and the Information System of the National Immunization Program (SIPNI).

The medical device cleaning market includes detergents and disinfectants used for cleaning and disinfection of medical instruments.

The market is primarily driven by rising incidence of hospital-acquired infections (HAIs) and the increasing focus on disinfection and sterilization of devices. Disinfection segment accounted for the largest share, owing to the increasing demand for high-level disinfectants & sterilization for heat-sensitive instruments.

Among instruments, surgical instruments segment accounted for the largest share of the market. This is primarily attributed to the increasing number of surgeries and rising awareness of HAIs. Geographically, North America held the largest share of this market.

During the forecast period, APAC region is expected to have high growth due to growing healthcare awareness, increasing number of hospitals and spending. Increasing adoption of single-use medical instruments to avoid HAI risks may restrain the market. Steris Plc is the leading market player.

The company has a comprehensive range of cleaning chemistries and sterility assurance cleansing products and a significant global presence.

One of the reason for higher cost is decreased productivity (USD2,529 million) as infants and adolescents with malnutrition have fewer years of schooling. In adults, it is not related to adequate quantity of food but nutritional value of the food.

The officials revealed that 1 of out 2 children are malnourished and they do not necessarily belong to the poor households. The country now faces duel burden of malnutrition. 2014 statistics showed that chronic malnutrition (delay in height) in the population under 5 years of age is 23.9% while overweight is 6.6%.

In school going population (aged 5 to 11), overweight is 19.1% and obesity is 12.1%. In adolescents (aged 12 to 19), overweight is 19.9% ​​and obesity is 7.8%.

The government has developed programs (Nutrition Action or Zero Malnutrition) to eradicate this duel burden and these programs are expected to have an impact on education and productivity.

The provinces of Morona Santiago, Chimborazo and Carchi present the highest prevalence of malnutrition in children aged 0-2 years with rates of 38% and 42.5%. Statistics showed that 64% of the adult population is overweight.

Ecuador aims to eradicating malnutrition by 2030 as a part of Sustainable Development Goals (SDG). Ministry of health mandated food labelling which highlights the amount of fat, salt and sugar processed products. Other plans include reduction of calories in food and specific taxes on high calorie drinks and similar ones.

Andorra ranked 1 globally, with 95 points on a scale ranging from 0 to 100. This was followed by Iceland (94) and Switzerland (92). Somalia (34), Afghanistan (32) and Central African Republic (29) were the bottom three countries.

Chile with 76 points ranked top amongst the countries of Latin America and the Caribbean (LATAM) followed by Cuba (74) and Argentina (68).

Amongst the LATAM countries, Guatemala (56), Honduras (56) and Haiti (38) were last in the ranking.

The model developed by Dr. Christopher Murray (USA) analyzed the evolution of the HAQ Index between 1990 and 2015 for each country. Of the 195 countries analyzed, 167 had significant improvements.

Study shows that in 1990 Chile scored 58.5. Chile focused on preventable diseases with high mortality.

The Ministry of Health emphasized in the 1990s on vaccination coverage to prevent infectious diseases such as measles, diphtheria and tetanus. Increasing public spending on health translating into more services for the population, including the strengthening of infrastructure and primary care. Also, all citizens of Chile have health coverage.

Each integral nuclear medicine center is expected to cost more than USD50 million and will work in coordination with the Center for Research and Development of Nuclear Technology to be installed in El Alto. The centers will be installed with the support of the Russian company Rosatom.

This nuclear research center will be contributing radioactive atoms to detect the cancer. Cancer detection can be performed in Bolivia and people will no longer have to travel to other countries for detection and treatment. The South American country plans to invest approximately USD 1 billion for the construction of hospitals for the next two years.